EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer

Maria J Ortiz-Ruiz, Olajumoke Popoola iD, Konstantinos Mitsopoulos, Robert Te-Poele iD, Rahul S Samant iD, Gary Box, Will Court, Alexis De Haven Brandon, Sharon Gowan, Aurelie Mallinger, Toby Roe, Kate Swabey und 9 weitere

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Maria J Ortiz-Ruiz und 20 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Protein Kinase Inhibitors, Cyclin-Dependent Kinase 8, Cyclin-Dependent Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK, Merck KGaA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsProtein Kinase InhibitorsCyclin-Dependent Kinase 8Cyclin-Dependent KinasesAntineoplastic AgentsMediator ComplexHumansAnimalsCell Line, TumorMicePyridinesPhosphorylationCell ProliferationXenograft Model Antitumor AssaysCyclin-Dependent Kinase-Activating Kinase

Substanzen

Protein Kinase InhibitorsCyclin-Dependent Kinase 8CDK8 protein, humanCyclin-Dependent KinasesCDK19 protein, humanAntineoplastic AgentsMediator ComplexPyridinesCyclin-Dependent Kinase-Activating Kinase

Autor:innen und Institutionen

  • Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K.
  • The Healthcare Business of Merck KGaA, 64293 Darmstadt, Germany.

ORCID-Profile: Olajumoke Popoola, Robert Te-Poele, Rahul S Samant, Paul Workman, Paul A Clarke

Förderung

  • Wellcome Trust
  • Cancer Research UK
  • Merck KGaA

Zitieren

APA

Ortiz-Ruiz, M. J., Popoola, O., Mitsopoulos, K., Te-Poele, R., Samant, R. S., Box, G., Court, W., Brandon, A. H., Gowan, S., Mallinger, A., Roe, T., Swabey, K., Valenti, M., Al-Lazikani, B., Blagg, J., Esdar, C., Schiemann, K., Wienke, D., Eccles, S. A., …, & Clarke, P. A. (2025). Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00338

Vancouver

Ortiz-Ruiz MJ, Popoola O, Mitsopoulos K, Te-Poele R, Samant RS, Box G, et al. Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00338

BibTeX
@article{OrtizRuiz2025,
  author = {Ortiz-Ruiz, Maria J and Popoola, Olajumoke and Mitsopoulos, Konstantinos and Te-Poele, Robert and Samant, Rahul S and Box, Gary and Court, Will and Brandon, Alexis De Haven and Gowan, Sharon and Mallinger, Aurelie and Roe, Toby and Swabey, Kate and Valenti, Melanie and Al-Lazikani, Bissan and Blagg, Julian and Esdar, Christina and Schiemann, Kai and Wienke, Dirk and Eccles, Suzanne A and Workman, Paul and Clarke, Paul A},
  title = {Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00338}
}
Kostenlos starten →